Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19B |
| 2 |
GE Vernova
GEV
|
+$1.16B |
| 3 |
Meta Platforms (Facebook)
META
|
+$501M |
| 4 |
Palantir
PLTR
|
+$451M |
| 5 |
DoorDash
DASH
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.22B |
| 2 |
Ascendis Pharma A/S
ASND
|
+$866M |
| 3 |
Applovin
APP
|
+$690M |
| 4 |
DAY
Dayforce
DAY
|
+$576M |
| 5 |
Workday
WDAY
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.5% |
| 2 | Healthcare | 20.49% |
| 3 | Industrials | 11.17% |
| 4 | Consumer Discretionary | 9.27% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Grand Canyon Education
LOPE
$3.71B
| $2.3M | ﹤0.01% |
13,511
+710
| +6% | +$119K |
|
1277
NewMarket
NEU
$7.17B
| $2.29M | ﹤0.01% |
3,583
| – | – |
|
1278
CNX Resources
CNX
$4.85B
| $2.29M | ﹤0.01% |
59,502
-6,200
| -9% | -$242K |
|
1279
F5
FFIV
$22.1B
| $2.29M | ﹤0.01% |
7,920
-465
| -6% | -$129K |
|
1280
Curtiss-Wright
CW
$27.7B
| $2.29M | ﹤0.01% |
3,360
-13,406
| -80% | -$8.92M |
|
1281
Royalty Pharma
RPRX
$26.1B
| $2.28M | ﹤0.01% |
47,589
-177
| -0.4% | -$7.75K |
|
1282
Equitable Holdings
EQH
$13.1B
| $2.28M | ﹤0.01% |
61,432
+27,052
| +79% | +$1.16M |
|
1283
Cenovus Energy
CVE
$54.6B
| $2.28M | ﹤0.01% |
86,167
| – | – |
|
1284
Arcosa
ACA
$7.12B
| $2.28M | ﹤0.01% |
21,444
| – | – |
|
1285
Mohawk Industries
MHK
$6.9B
| $2.28M | ﹤0.01% |
23,130
| – | – |
|
1286
REX American Resources
REX
$1.46B
| $2.27M | ﹤0.01% |
49,840
| – | – |
|
1287
Zimmer Biomet
ZBH
$17.7B
| $2.26M | ﹤0.01% |
25,021
-1,142
| -4% | -$105K |
|
1288
VSE Corp
VSEC
$5.48B
| $2.25M | ﹤0.01% |
12,184
+1,875
| +18% | +$382K |
|
1289
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $2.23M | ﹤0.01% |
15,066
-267
| -2% | -$40.1K |
|
1290
Dave Inc
DAVE
$5.12B
| $2.23M | ﹤0.01% |
12,805
+230
| +2% | +$44.7K |
|
1291
Estee Lauder
EL
$29B
| $2.23M | ﹤0.01% |
31,058
+6,184
| +25% | +$632K |
|
1292
Beam Therapeutics
BEAM
$2.58B
| $2.22M | ﹤0.01% |
93,253
+53,752
| +136% | +$1.49M |
|
1293
Macy's
M
$6.15B
| $2.21M | ﹤0.01% |
122,217
| – | – |
|
1294
Bank OZK
OZK
$5.49B
| $2.21M | ﹤0.01% |
48,087
| – | – |
|
1295
Bio-Rad Laboratories Class A
BIO
$8.42B
| $2.2M | ﹤0.01% |
7,900
| – | – |
|
1296
Plains GP Holdings
PAGP
$5.23B
| $2.2M | ﹤0.01% |
90,500
| – | – |
|
1297
Home BancShares
HOMB
$6.21B
| $2.2M | ﹤0.01% |
81,548
| – | – |
|
1298
Hess Midstream
HESM
$5.22B
| $2.19M | ﹤0.01% |
56,416
-172,726
| -75% | -$6.4M |
|
|
HUT
1299
Hut 8
HUT
$12.4B
| $2.18M | ﹤0.01% |
46,500
| – | – |
|
1300
D-Wave Quantum
QBTS
$6B
| $2.18M | ﹤0.01% |
151,073
-42,257
| -22% | -$894K |
|
Similar funds
Janus Henderson Group's Q1 2026 Portfolio in Review
As of Q1 2026, Janus Henderson Group held 2,488 positions worth $209B, down 6.2% from $223B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Janus Henderson Group's Q1 2026 filing shows 82 new, 739 increased, 627 reduced and 81 closed positions. Its largest new stake was Forgent Power Solutions: 7,769,612 shares worth $227M. The largest sale was Microsoft, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2026 buy was Forgent Power Solutions: 7,769,612 shares worth $227M.
- Janus Henderson Group added most to AstraZeneca in Q1 2026, an estimated $2.19B increase.
- Janus Henderson Group's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Ascendis Pharma A/S in Q1 2026, selling an estimated $866M.
- Janus Henderson Group's ten largest holdings make up 30% of its $209B portfolio in Q1 2026.
- Janus Henderson Group opened 82 new positions and closed 81 in Q1 2026.
- Janus Henderson Group's portfolio value fell 6.2% quarter-over-quarter to $209B.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.